GlassScriptPhysician profile
Denis Huang
NPI 1699390773
$2,640.03
in general payments reported to CMS, 2019-2025
13 companies · $1,191 in 2025
The $1,191 reported for 2025 was more than what 77% of Retina Specialist providers received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $274 · 2023: $478 · 2024: $697 · 2025: $1,191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,366.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $862.29 | 2022-2025 | Centurion, Clareon, Argos |
| Regeneron Healthcare Solutions, INC. | $559.49 | 2024-2025 | Eylea Hd |
| Genentech USA, INC. | $209.76 | 2024-2025 | Susvimo, Vabysmo |
| Dutch Ophthalmic, USA | $183.99 | 2024-2025 | Eva, Combined Machine, Tissueblue |
| Alimera Sciences, INC. | $140.75 | 2024 | Iluvien, Yutiq |
| Regeneron Pharmaceuticals, INC. | $138.46 | 2025 | Eylea Hd |
| Samsara Vision | $115.38 | 2025 | Implantable Miniature Telescope (Imt By Dr. Isaac Lipshitz) |
| Astellas Pharma US INC | $101.32 | 2025 | Izervay |
| Allergan, INC. | $99.99 | 2022 | |
| Abbvie INC. | $78.86 | 2024-2025 | |
| Eyepoint US, INC. | $61.80 | 2024 | |
| Apellis Pharmaceuticals, INC. | $60.48 | 2024 | Syfovre |
| Ani Pharmaceuticals, INC. | $27.46 | 2025 | Yutiq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Denis Huang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.